Protalix Biotherapeutics, Inc. (PLX)
2.53
+0.05
(+2.02%)
USD |
NYAM |
Oct 27, 16:00
2.515
-0.02
(-0.59%)
After-Hours: 20:00
Protalix Biotherapeutics Price : 2.53 for Oct. 27, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 27, 2026 | 2.48 | 2.545 | 2.46 | 2.53 | 448304.0 |
| Oct 26, 2026 | 2.55 | 2.55 | 2.46 | 2.48 | 416271.0 |
| Oct 23, 2026 | 2.54 | 2.56 | 2.495 | 2.55 | 383908.0 |
| Oct 22, 2026 | 2.53 | 2.60 | 2.53 | 2.57 | 457114.0 |
| Oct 21, 2026 | 2.60 | 2.635 | 2.53 | 2.57 | 561517.0 |
| Oct 20, 2026 | 2.58 | 2.65 | 2.578 | 2.64 | 702710.0 |
| Oct 19, 2026 | 2.63 | 2.66 | 2.535 | 2.56 | 914833.0 |
| Oct 16, 2026 | 2.70 | 2.70 | 2.61 | 2.62 | 1.189M |
| Oct 15, 2026 | 2.63 | 2.75 | 2.62 | 2.70 | 1.139M |
| Oct 14, 2026 | 2.73 | 2.775 | 2.61 | 2.61 | 1.533M |
| Oct 13, 2026 | 2.80 | 2.80 | 2.735 | 2.75 | 967788.0 |
| Oct 12, 2026 | 2.75 | 2.80 | 2.71 | 2.78 | 717139.0 |
| Oct 09, 2026 | 2.70 | 2.785 | 2.69 | 2.78 | 1.199M |
| Oct 08, 2026 | 2.68 | 2.71 | 2.61 | 2.70 | 972851.0 |
| Oct 07, 2026 | 2.70 | 2.765 | 2.68 | 2.71 | 794735.0 |
| Oct 06, 2026 | 2.74 | 2.76 | 2.65 | 2.73 | 934737.0 |
| Oct 05, 2026 | 2.68 | 2.74 | 2.65 | 2.71 | 984061.0 |
| Oct 02, 2026 | 2.70 | 2.72 | 2.64 | 2.71 | 947405.0 |
| Oct 01, 2026 | 2.77 | 2.77 | 2.60 | 2.68 | 1.589M |
| Sep 30, 2026 | 2.69 | 2.815 | 2.68 | 2.76 | 836259.0 |
| Sep 29, 2026 | 2.69 | 2.735 | 2.680 | 2.69 | 898556.0 |
| Sep 28, 2026 | 2.71 | 2.72 | 2.61 | 2.69 | 832815.0 |
| Sep 25, 2026 | 2.76 | 2.775 | 2.70 | 2.72 | 386025.0 |
| Sep 24, 2026 | 2.78 | 2.817 | 2.73 | 2.75 | 302700.0 |
| Sep 23, 2026 | 2.84 | 2.850 | 2.765 | 2.80 | 586410.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Altimmune, Inc. | 2.04 |
| Taysha Gene Therapies, Inc. | 4.25 |
| Humacyte, Inc. | 0.4463 |
| Agenus, Inc. | 6.65 |
| Amgen, Inc. | 447.95 |
Price Related Metrics
| PE Ratio | 11.14 |
| PS Ratio | 2.564 |
| PEG Ratio | 0.0538 |
| Price to Book Value | 2.855 |
| Price to Free Cash Flow | 26.96 |
| Earnings Yield | 8.98% |
| Market Cap | 203.85M |
| PEGY Ratio | 0.0538 |
| Operating PE Ratio | 8.876 |
| Normalized PE Ratio | 11.15 |